PMDA and the Ministry of Health, Labour and Welfare of Japan (MHLW) give importance to regulatory dialogue regarding medical products, as well as other relevant matters in view of strengthening the relationship and promoting the cooperation with the Food and Drug Administration Philippines (FDA Philippines), the regulatory authority for medical products. The FDA Philippines, the Ministry of Health, Labour and Welfare of Japan (MHLW), and the Pharmaceuticals and Medical Devices Agency (PMDA) concluded the Memorandum of Cooperation (MOC) in 2025. Based on this MOC, PMDA organizes some seminars for FDA Philippines.
Memorandum of Cooperation
Philippines (FDA Philippines)
Memorandum of Cooperation (April 2025)
Seminar
PMDA holds the ATC seminar for FDA Philippines based on their requests.
[FY2025]
Clinical Trial
Date: February 5, 2026
Location: Online
Number of participants: 34
Report
[FY2024]
Radiopharmaceuticals Review
Date: Novemver 19, 2024
Location: Online
Number of participants: 19
Report
[FY2023]
Pharmaceutical Review, Pharmacovigilance
Date: December 14 and 15, 2023
Location: Online
Number of participants: 52(Pharmaceutical Review), 50(Pharmacovigilance)
Report
For other seminars, please click the Seminar Schedule page.